Diaxonhit Signs a Research Service Agreement with Boehringer Ingelheim
05-Sep-2013
- France
“This agreement with Boehringer Ingelheim demonstrates the continued interest in and effectiveness of our SpliceArrayTM discovery platform, and the expertise we have efficiently developed to exploit our comprehensive transcriptomic data for new target discovery ” said Loïc Maurel M.D., President of Diaxonhit’s Management Board.
Financial terms were not disclosed.
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.